So you have the opioid and the agonist on the same bead, and that's why they have the manufacturing problems that they have. It's difficult to do all on one bead.
fda prefers 2 bead
wrong they never said that was all they wanted. more misguide bs posts from you
The share price sure reflects the Apple of the bio world that's for sure.
FDA likes it. Easily understandable.
one bead not stable
Modular too for use on ALL OPIODS
seems the market doesn't agree
That is why all the problems with the ALO-02
Best abuse resistant tech out there.